These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 33722453)
21. The Effectiveness of Facial Neuromuscular Retraining on Patients with Facial Nerve Dysfunction: A Mental Health and Quality of Life Analysis. Rostami S; Min S; McCann A; Sayers C; Samy R; Collar R; Hsieh TY Facial Plast Surg Aesthet Med; 2024; 26(5):551-557. PubMed ID: 38635958 [No Abstract] [Full Text] [Related]
22. Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation. Ito H; Ito H; Nakano S; Kusaka H Acta Neurol Scand; 2007 Apr; 115(4):271-4. PubMed ID: 17376126 [TBL] [Abstract][Full Text] [Related]
23. Validation of the Synkinesis Assessment Questionnaire. Mehta RP; WernickRobinson M; Hadlock TA Laryngoscope; 2007 May; 117(5):923-6. PubMed ID: 17473697 [TBL] [Abstract][Full Text] [Related]
24. Measuring the Potential Effects of Mirror Therapy Added to the Gold Standard Facial Neuromuscular Retraining in Patients With Chronic Peripheral Facial Palsy: Protocol for a Randomized Controlled Trial. Dagenais F; Neville C; Desmet L; Martineau S JMIR Res Protoc; 2023 Jul; 12():e47709. PubMed ID: 37418307 [TBL] [Abstract][Full Text] [Related]
26. Objective Assessment of the Repeated Botox Treatment to the Synkinesis of Facial Paralysis by the Integrated Electromyography. Homma T; Uemura N; Tanaka K; Mori H; Okazaki M J Craniofac Surg; 2024 Mar-Apr 01; 35(2):577-581. PubMed ID: 38231192 [TBL] [Abstract][Full Text] [Related]
27. Quantitative measurement of evolution of postparetic ocular synkinesis treated with botulinum toxin type A. Cecini M; Pavese C; Comelli M; Carlisi E; Sala V; Bejor M; Toffola ED Plast Reconstr Surg; 2013 Nov; 132(5):1255-1264. PubMed ID: 24165606 [TBL] [Abstract][Full Text] [Related]
28. Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis. Shinn JR; Nwabueze NN; Du L; Patel PN; Motamedi KK; Norton C; Ries WR; Stephan SJ JAMA Facial Plast Surg; 2019 May; 21(3):244-251. PubMed ID: 30703206 [TBL] [Abstract][Full Text] [Related]
29. Combined protocol for treatment of secondary effects from facial nerve palsy. Monini S; De Carlo A; Biagini M; Buffoni A; Volpini L; Lazzarino AI; Barbara M Acta Otolaryngol; 2011 Aug; 131(8):882-6. PubMed ID: 21534714 [TBL] [Abstract][Full Text] [Related]
30. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis. Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443 [TBL] [Abstract][Full Text] [Related]
31. Treating Buccinator With Botulinum Toxin in Patients With Facial Synkinesis: A Previously Overlooked Target. Wei LA; Diels J; Lucarelli MJ Ophthalmic Plast Reconstr Surg; 2016; 32(2):138-41. PubMed ID: 26325382 [TBL] [Abstract][Full Text] [Related]
32. Facial Clinimetric Evaluation Scale and Synkinesis Assessment Questionnaire Translation into Brazilian Portuguese: A Validation Study. Tavares-Brito J; Fonseca ACO; Torres RP; van Veen MM; Greene J; Salomone R; Bahmad F; Hadlock T; Bento RF Int Arch Otorhinolaryngol; 2020 Jan; 24(1):e24-e30. PubMed ID: 31915465 [No Abstract] [Full Text] [Related]
34. Buccinator synkinesis treated by botulinum toxin in facial palsy and hemifacial spasms. Kanerva M J Plast Reconstr Aesthet Surg; 2021 Jul; 74(7):1464-1469. PubMed ID: 33358465 [TBL] [Abstract][Full Text] [Related]
35. Individualized management of facial synkinesis based on facial function. Maria CM; Kim J Acta Otolaryngol; 2017 Sep; 137(9):1010-1015. PubMed ID: 28471705 [TBL] [Abstract][Full Text] [Related]
36. Masseteric-to-Facial Nerve Transfer and Selective Neurectomy for Rehabilitation of the Synkinetic Smile. Vincent AG; Bevans SE; Robitschek JM; Wind GG; Hohman MH JAMA Facial Plast Surg; 2019 Dec; 21(6):504-510. PubMed ID: 31465094 [TBL] [Abstract][Full Text] [Related]
37. Validation of the Spanish version of the Sunnybrook facial grading system. Sanchez-Cuadrado I; Mato-Patino T; Morales-Puebla JM; Peñarrocha J; Diez-Sebastian J; Gavilán J; Lassaletta L Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):543-548. PubMed ID: 35737100 [TBL] [Abstract][Full Text] [Related]
38. Subjective and Objective Measures in the Treatment of Hemifacial Spasm With OnabotulinumtoxinA. Chundury RV; D'Angelo AS; Couch SM; Holds JB Ophthalmic Plast Reconstr Surg; 2016; 32(2):133-7. PubMed ID: 25811161 [TBL] [Abstract][Full Text] [Related]
39. Neuromuscular retraining therapy for early stage severe Bell's palsy patients minimizes facial synkinesis. Kim DR; Kim JH; Jung SH; Won YJ; Seo SM; Park JS; Kim WS; Kim GC; Kim J Clin Rehabil; 2023 Nov; 37(11):1510-1520. PubMed ID: 36972474 [TBL] [Abstract][Full Text] [Related]
40. [Rehabilitation of patients with complications of facial nerve neuropathy]. Zavaliy LB; Sinkin MV; Ramazanov GR; Petrikov SS Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(11):90-94. PubMed ID: 37994893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]